Incore Lapidus
Payments companies reported to CMS as associated with Incore Lapidus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Incore Lapidus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Incore Lapidus
These are the largest totals companies reported as associated with Incore Lapidus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brett Sachs | Wheat Ridge, CO | Foot & Ankle Surgery | $33,102.68 |
| Michael Johnson | Birmingham, AL | Orthopaedic Surgery | $12,596.77 |
| Justin Raatz | Des Moines, IA | Foot & Ankle Surgery | $8,014.71 |
| Michael Aynardi | Hershey, PA | Orthopaedic Surgery | $3,250.00 |
| Tyson Green | Lake Charles, LA | Foot & Ankle Surgery | $1,959.58 |
| Wesley Leong | Roanoke, VA | Foot & Ankle Surgery | $1,882.21 |
| Sharif Abdelfattah | Sullivan, IN | Foot & Ankle Surgery | $1,799.02 |
| Brian Haselsberger | Rochester, NY | Podiatrist | $1,458.23 |
| Andrew Harston | Louisville, KY | Orthopaedic Surgery | $1,299.57 |
| Michael Doss | Port St Lucie, FL | Foot & Ankle Surgery | $1,212.41 |
Prescribed Incore Lapidus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.